Show simple item record

dc.contributor.authorSmith, V.
dc.contributor.authorMukherjee, D.
dc.contributor.authorTsakiroglou, A. M.
dc.contributor.authorBaker, Alexander
dc.contributor.authorMistry, H.
dc.contributor.authorChoudhury, A.
dc.contributor.authorHoskin, P.
dc.contributor.authorIllidge, T.
dc.contributor.authorWest, C.
dc.date.accessioned2023-05-17T09:50:51Z
dc.date.available2023-05-17T09:50:51Z
dc.date.issued2022en
dc.identifier.citationSmith V, Mukherjee D, Tsakiroglou AM, Baker A, Mistry H, Choudhury A, et al. Low CD8 T cells predicts benefit from hypoxia-modifying therapy in bladder cancer. Cancer Research. 2022 Jun;82(12). PubMed PMID: WOS:000892509500367.en
dc.identifier.doi10.1158/1538-7445.AM2022-6236en
dc.identifier.urihttp://hdl.handle.net/10541/626259
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1158/1538-7445.AM2022-6236en
dc.titleLow CD8 T cells predicts benefit from hypoxia-modifying therapy in bladder canceren
dc.typeMeetings and Proceedingsen
dc.contributor.departmentUniversity of Manchester, Manchesteren
dc.identifier.journalCancer Researchen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record